Popularity #149Dividend on the way · $0.21
Kenvue (KVUE)
Markets OTC medicines and personal-care brands including Tylenol, Neutrogena, and Listerine worldwide.
$17.86
After hours−0.02 (−0.08%)
At close$17.88(+1.16%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 41 days
EPS estimate
$0.28
Revenue estimate
$3.86B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.26$0.24$0.29$0.28$0.27$0.32$0.31Pending
Estimate$0.26$0.23$0.28$0.26$0.22$0.26$0.32$0.28
Surprise0.0%+5.5%+2.9%+7.6%+21.2%+22.1%−2.7%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$3.66B$3.74B$3.84B$3.76B$3.78B$3.91B$3.96BPending
Estimate$3.76B$3.68B$3.85B$3.82B$3.69B$3.84B$3.97B$3.86B
Surprise−2.6%+1.7%−0.4%−1.5%+2.6%+1.7%−0.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.30 | — | — |
| Sep 2028 | $0.34 | — | — |
| Jun 2028 | $0.35 | — | — |
| Mar 2028 | $0.35 | — | — |
| Dec 2027 | $0.28 | — | — |
| Sep 2027 | $0.30 | — | — |
| Jun 2027 | $0.32 | — | — |
| Mar 2027 | $0.33 | — | — |
| Dec 2026 | $0.26 | — | — |
| Nov 2026 | $0.28 | — | — |
| Aug 2026 | $0.32 | $0.31 | −2.7% |
| May 2026 | $0.26 | $0.32 | +22.1% |
| Feb 2026 | $0.22 | $0.27 | +21.2% |
| Nov 2025 | $0.26 | $0.28 | +7.6% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Jan 2023 | |||
| Oct 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.30 | — | — | $4.10B | — | — | — |
| Sep 2028 | $0.34 | — | — | $4.12B | — | — | — |
| Jun 2028 | $0.35 | — | — | $4.21B | — | — | — |
| Mar 2028 | $0.35 | — | — | $4.16B | — | — | — |
| Dec 2027 | $0.28 | — | — | $3.92B | — | — | — |
| Sep 2027 | $0.30 | — | — | $3.93B | — | — | — |
| Jun 2027 | $0.32 | — | — | $4.05B | — | — | — |
| Mar 2027 | $0.33 | — | — | $4.00B | — | — | — |
| Dec 2026 | $0.26 | — | — | $3.88B | — | — | — |
| Nov 2, 2026 | $0.28 | — | — | $3.86B | — | — | — |
| Aug 6, 2026 | $0.32 | $0.31 | −2.7% | $3.97B | $3.96B | −0.3% | −2.5% |
| May 7, 2026 | $0.26 | $0.32 | +22.1% | $3.84B | $3.91B | +1.7% | +0.2% |
| Feb 17, 2026 | $0.22 | $0.27 | +21.2% | $3.69B | $3.78B | +2.6% | +2.6% |
| Nov 3, 2025 | $0.26 | $0.28 | +7.6% | $3.82B | $3.76B | −1.5% | +12.3% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 6, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 8, 2024 | |||||||
| Oct 26, 2023 | |||||||
| Jul 20, 2023 | |||||||
| Jun 2, 2023 | |||||||
| Mar 3, 2023 | |||||||
| Jan 1, 2023 | |||||||
| Oct 2, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 |